In this issue:
- BNT162b2 COVID-19 vaccine in children aged 5–11 years
- Effectiveness of BNT162b2 vaccine against COVID-19 in adolescents
- VE of BNT162b2 against COVID-19 in adolescents
- COVID-19 spread in paediatric patients during the Omicron surge
- Risk factors for severe COVID-19 in children
- Unlocking conspiracy belief systems
- Can wearable devices predict antibody response to COVID-19 vaccination?
- Insights from an Australian COVID-19 mass vaccination clinic
- Immunisation stress-related response
- Incidence of immunisation stress-related response after COVID-19 vaccination
Download PDF